Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.

Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolledPart A 16-week proof-of-concept data ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

Apogee begins patient dosing in Part B of phase 2 APEX trial of APG777 to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 4, 2025, 18:00 Hrs [IST] Apog ...

The spotlight on AZ – thought to have the largest presence in China of any ... trial in patients with chronic rhinosinusitis with nasal polyps (CRwNP). The WAYPOINT trial showed that TSLP ...

Aspirin is contraindicated in patients with known allergy to NSAIDs and in patients with the triad of asthma, rhinitis, and nasal polyps ... 2%). A large number of adverse reactions due to ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...

People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...

This is why colon cancer screenings are so important. Adenomatous polyps can form anywhere in the large intestine. There is no known way to prevent polyps from growing altogether, although some known ...